Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 1;57(5):333-339.
doi: 10.3928/01913913-20200804-01.

Development of Screening Criteria for Retinopathy of Prematurity in Ulaanbaatar, Mongolia, Using a Web-based Data Management System

Development of Screening Criteria for Retinopathy of Prematurity in Ulaanbaatar, Mongolia, Using a Web-based Data Management System

Shelbi L Olson et al. J Pediatr Ophthalmol Strabismus. .

Abstract

Purpose: To describe a process for identifying birth weight (BW) and gestational age (GA) screening guidelines in Mongolia.

Methods: This was a prospective cohort study in a tertiary care hospital in Ulaanbataar, Mongolia, of 193 premature infants with GA of 36 weeks or younger and/or BW of 2,000 g or less) with regression analysis to determine associations between BW and GA and the development of retinopathy of prematurity (ROP).

Results: As BW and GA decreased, the relative risk of developing ROP increased. The relative risk of developing any stage of ROP in infants born at 29 weeks or younger was 2.91 (95% CI: 1.55 to 5.44; P < .001] compared to older infants. The relative risk of developing any type of ROP in infants with BW of less than 1,200 g was 2.41 (95% CI: 1.35 to 4.29; P = .003] and developing type 2 or worse ROP was 2.05 (95% CI: 0.99 to 4.25; P = .05).

Conclusions: Infants in Mongolia with heavier BW and older GA who fall outside of current United States screening guidelines of GA of 30 weeks or younger and/or BW of 1,500 g or less developed clinically relevant ROP. [J Pediatr Ophthalmol Strabismus. 2020;57(5):333-339.].

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Distribution of birth weight (BW) and gestational age (GA) in the cohort of patients analyzed.
Figure 2.
Figure 2.
An example of a patient who was treated with anti-vascular endothelial growth factor for aggressive posterior retinopathy of prematurity at post-menstrual age of 34 weeks. The patient’s gestational age was 29 weeks and birth weight was 1,250 g. The image on the left is a temporal view and the image on the right is the inferior view. Both images are from the same patient.

References

    1. Palmer EA, Hardy RJ, Dobson V, et al. 15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol. 2005;123(3):311–318. - PubMed
    1. Good WV; Early Treatment for Retinopathy of Prematurity Co-operative Group. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc. 2004;102:233–248. - PMC - PubMed
    1. Fierson WM, American Academy of Pediatrics Section on Ophthalmology, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus; American Association of Certified Orthoptists. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2013;131(1):189–195. doi:10.1542/peds.2012-2996 - DOI - PubMed
    1. Sommer A, Taylor HR, Ravilla TD, et al.; Council of the American Ophthalmological Society. Challenges of ophthalmic care in the developing world. JAMA Ophthalmol. 2014;132(5):640–644. doi:10.1001/jamaophthalmol.2014.84 - DOI - PMC - PubMed
    1. Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of infants at risk and implications for control. Early Hum Dev. 2008;84(2):77–82. doi:10.1016/j.earlhumdev.2007.11.009 - DOI - PubMed